Lifestyle program to prevent muscle loss in older adults with diabetes on semaglutide
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether a lifestyle program (diet and exercise) can help prevent muscle loss in people 65 and older with type 2 diabetes and obesity who are taking semaglutide. It may help you keep your strength and independence while losing weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have type 2 diabetes.
- You are overweight or obese (BMI 27 or higher).
- You have not taken weight-loss drugs (including semaglutide) in the last 3 months.
- You are not currently following a strict diet or weight-loss program (more than 5% loss in 3 months).
- You can exercise safely (no major hearing/vision problems, no walking aid, no recent hospitalization, and no conditions that limit exercise).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
This study tests whether taking HMB (a supplement) and vitamin D helps older adults keep their muscle while using semaglutide for weight loss. If you are starting semaglutide, this might help prevent muscle loss.
This study tests whether a 12-week program of exercise and personalized nutrition can help adults who are obese and taking GLP-1 weight-loss medications maintain muscle and bone while losing fat. It aims to improve strength, fitness, and overall function during treatment.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study tests a programme that combines medical, dietary, and behavioural support to help adults with obesity lose weight and improve their health. It looks at how well the programme works in everyday clinic settings.
Hear when a new Type 2 Diabetes Mellitus in Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.